Portfolio company
Human Biome
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MRM Health
This biopharmaceutical company develops microbiome-based live biotherapeutic products for patients with chronic inflammatory diseases and immune-oncology conditions.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
Bloom Science
This biotechnology company develops microbiome-based oral therapeutics for patients with rare neurological conditions and metabolic disorders like obesity and epilepsy.
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
Metabogen
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
Enterbiotix
This company develops orally administered microbiome therapeutics to treat patients with gastrointestinal conditions including irritable bowel syndrome and liver cirrhosis.
Vedanta Biosciences
This company develops microbiome-based oral therapies using bacterial consortia to treat patients with gastrointestinal and immune-mediated diseases.
